Loading...
Loading...
Available on 1 platform
Sign in to view source links and access this dataset
Hong Kong and Asia-Pacific clinicians developed 42 consensus statements on managing locally advanced and metastatic renal cell carcinoma. The statements were established via a Delphi process with a panel of 14 experts and an 80% voting threshold. The document updates previous guidelines with new areas like adjuvant therapy, immunotherapy combinations, and definitions for oligometastatic disease.
Data is contained within a DOCX document; analysis requires text parsing or manual review.